Amyloid
Showing 26 - 50 of 1,651
Transthyretin Amyloid Polyneuropathy (ATTR-PN) Trial in China (tafamidis meglumine)
Active, not recruiting
- Transthyretin Amyloid Polyneuropathy (ATTR-PN)
- tafamidis meglumine
-
Beijing, Beijing, China
- +7 more
Nov 21, 2022
Aortic Stenosis and Cardiac Amyloidosis
Recruiting
- Cardiac Amyloidosis
- Aortic Stenosis
- Amyloid-specific treatment
- No amyloid-specific treatment
-
Vienna, Austria
- +1 more
Nov 8, 2023
MRI-markers to Monitor Small Vessel Disease Dynamics in
Recruiting
- Intracerebral Hemorrhage
- +2 more
- Combined 3- and 7 Tesla-MRI
-
Bern, SwitzerlandDepartment of Neurology, Inselspital Bern University Hospital
Mar 6, 2023
Frail Elderly Trial in Toulouse (MRI and PET scan)
Active, not recruiting
- Frail Elderly
- MRI and PET scan
-
Toulouse, FranceToulouse University Hospital (CHU de Toulouse)
Oct 13, 2022
Alzheimer Trial in Boston (Transcranial Alternating Current Stimulation (tACS))
Completed
- Alzheimer Disease
- Transcranial Alternating Current Stimulation (tACS)
-
Boston, MassachusettsBeth Israel Deaconess Medical Center
Aug 18, 2022
Hypertension Trial in Dallas (Standard Care, Intensive Treatment)
Active, not recruiting
- Hypertension
- Standard Care
- Intensive Treatment
-
Dallas, TexasUT Southwestern Medical Center
Aug 11, 2022
Amyloidosis, Primary, Cardiomyopathy Trial in Boston (F-18 florbetapir/C-11 acetate PET, MRI, N-13 ammonia PET)
Recruiting
- Amyloidosis, Primary
- Cardiomyopathy
- F-18 florbetapir/C-11 acetate PET
- +2 more
-
Boston, MassachusettsBrigham and Womens' Hospital
Oct 23, 2022
Artificial Intelligence-based Computer Aided Diagnosis Software
Completed
- Alzheimer Disease
- Mild Cognitive Impairment
- NeuroAI
-
Gwangju, Korea, Republic ofChonnam National University Hospital
Sep 14, 2022
Transthyretin-Related (ATTR) Familial Amyloid Polyneuropathy Trial (Acoramidis)
Withdrawn
- Transthyretin-Related (ATTR) Familial Amyloid Polyneuropathy
- (no location specified)
Jan 26, 2022
Small Vessel Disease Markers After Intracerebral Hemorrhage
Recruiting
- Cerebral Amyloid Angiopathy
- +3 more
-
Leiden, Zuid-Holland, NetherlandsLeiden University Medical Center
Aug 10, 2022
Multiple Sclerosis Trial in Pavia (18F-florbetaben PET/CT)
Recruiting
- Multiple Sclerosis
- 18F-florbetaben PET/CT
-
Pavia, PV, ItalyICS Maugeri SpA SB IRCCS
Mar 23, 2023
Cerebral Amyloid Angiopathy Trial in France (neurological, neuropsychological and MRI evaluation)
Recruiting
- Cerebral Amyloid Angiopathy
- neurological, neuropsychological and MRI evaluation
-
Bordeaux, France
- +3 more
Mar 15, 2022
Diabetic Pancreatic Amyloid Deposition on Cognitive Dysfunction
Recruiting
- AD
- +2 more
-
Shanghai, ChinaHuashan Hospital
May 8, 2022
Systemic Amyloidosis Trial in Knoxville (99mTc-p5+14 is an amyloid reactive peptide labeled with technetium-99m.,
Recruiting
- Systemic Amyloidosis
- 99mTc-p5+14 is an amyloid reactive peptide labeled with technetium-99m.
- 99mTc-Pyrophosphate and 99mtc-p5+14 - an Amyloid Reactive Peptide Labeled With Technetium-99m.
-
Knoxville, TennesseeUniversity of Tennessee Graduate School of Medicine
Jul 10, 2023
OCTA Factors in or Without Amyloid Pathology: A Prospective
Completed
- Alzheimer Disease
- +4 more
-
Busan, Korea, Republic ofPusan National University Hospital
Jul 24, 2022
Cognitive Health in Ageing Register: Investigational,
Active, not recruiting
- Alzheimer's Disease
- Plaque, Amyloid
-
Edinburgh, United Kingdom
- +1 more
Jan 31, 2023
Hereditary Transthyretin Amyloidosis
Recruiting
- Amyloidosis
- +6 more
-
Cleveland, OhioCleveland Clinic
Mar 11, 2022
Cerebral Amyloid Angiopathy Trial in Beijing (Remote ischemic conditioning)
Recruiting
- Cerebral Amyloid Angiopathy
- Remote ischemic conditioning
-
Beijing, Beijing, ChinaXuan Wu Hospital，Capital Medical University
Jan 12, 2022
Mild Cognitive Impairment Trial in San Francisco (Transcranial alternating current stimulation)
Completed
- Mild Cognitive Impairment
- Transcranial alternating current stimulation
-
San Francisco, CaliforniaUniversity of California, San Francisco
Aug 2, 2022
Bioavailability, Gut Microbiome, Safety Trial in Lubbock (Low curcumin group, High curcumin group)
Not yet recruiting
- Bioavailability
- +2 more
- Low curcumin group
- High curcumin group
-
Lubbock, TexasTexas Tech University Health Sciences Center
Mar 15, 2023
Transthyretin-Related (ATTR) Familial Amyloid Polyneuropathy, Transthyretin-Related (ATTR) Familial Amyloid Cardiomyopathy,
Recruiting
- Transthyretin-Related (ATTR) Familial Amyloid Polyneuropathy
- +2 more
- NTLA-2001
-
Paris, France
- +3 more
Nov 29, 2022
Transthyretin Amyloidosis Trial in New York (I 124-Evuzamitide)
Recruiting
- Transthyretin Amyloidosis
- I 124-Evuzamitide
-
New York, New YorkColumbia University Irving Medical Center
Nov 23, 2022
Normal Physiology Trial run by the National Institute on Alcohol Abuse and Alcoholism (NIAAA) ([18F]florbetaben)
Completed
- Normal Physiology
- [18F]florbetaben
-
Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
Aug 18, 2022
Imaging of Brain Structural/Functional Connectivity and Amyloid
Recruiting
- Alzheimer Disease
- F 18 T807 Flortaucipir
-
Saint Louis, MissouriWashington University School of Medicine
Sep 23, 2022
Cognitively Normal Older Adults, Hypertension, Subjective Cognitive Decline Trial in Dallas (Angiotensin II Receptor Blockers
Recruiting
- Cognitively Normal Older Adults
- +3 more
- Angiotensin II Receptor Blockers (ARBs, losartan) and Calcium Channel Blockers (CCB, amlodipine)
- PCP
-
Dallas, TexasUniversity of Texas Southwestern Medical Center
Dec 1, 2022